Corporate Regulation

Enrico Vita's strategy to build a vertically integrated global hearing care player faces regulatory scrutiny across multiple jurisdictions. Competition authorities may demand divestitures or block transactions outright as consolidation accelerates in the hearing care sector.

Quikrete Holdings' proposed $11.5 billion acquisition of Summit Materials confronts medium-likelihood but catastrophic regulatory risk as antitrust authorities examine combined market power in construction materials. The deal would consolidate positions across aggregates, ready-mix concrete, and building products—sectors already facing regulatory scrutiny for concentration. Shareholder value hinges on clearance strategy and potential divestiture costs.